Evaluation of solubility enhancement, antioxidant activity, and cytotoxicity studies of kynurenic acid loaded cyclodextrin nanosponge.


Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
15 Nov 2019
Historique:
received: 20 04 2019
revised: 01 08 2019
accepted: 03 08 2019
entrez: 2 9 2019
pubmed: 2 9 2019
medline: 6 2 2020
Statut: ppublish

Résumé

Kynurenic acid demonstrates antioxidant, neuroprotective and free radical scavenging properties. However, low aqueous solubility of kynurenic acid limits its therapeutic activity. In the present study, cyclodextrin nanosponges were used to improve the solubility and therapeutic activity of kynurenic acid. The formation of kynurenic acid loaded nanosponge was confirmed by different characterization techniques. The solubility of kynurenic acid was significantly increased with nanosponge (111.1 μg/ml) compared to free kynurenic acid (16.4 μg/ml) and β-cyclodextrin (28.6 μg/ml). High drug loading (19.06%) and encapsulation efficiency (95.31%) were achieved with NS. The particle size and zeta potential of kynurenic acid loaded nanosponge was around 255.8 nm and -23 mV respectively. Moreover, higher solubilization of kynurenic acid loaded nanosponge produced better antioxidant activity compared to free kynurenic acid. The kynurenic acid loaded nanosponge and blank nanosponge were found nontoxic in the cytotoxicity assay. Thus, these studies demonstrated that nanosponges can be used as a carrier for the delivery of kynurenic acid.

Identifiants

pubmed: 31472867
pii: S0144-8617(19)30835-5
doi: 10.1016/j.carbpol.2019.115168
pii:
doi:

Substances chimiques

Cyclodextrins 0
Drug Carriers 0
Free Radical Scavengers 0
Kynurenic Acid H030S2S85J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115168

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Nilesh K Dhakar (NK)

Department of Chemistry, University of Torino, via P. Giuria 7, 10125, Torino, Italy.

Fabrizio Caldera (F)

Department of Chemistry, University of Torino, via P. Giuria 7, 10125, Torino, Italy.

Federica Bessone (F)

Department of Drug Science and Technology, University of Torino, via P. Giuria 9, 10125, Torino, Italy.

Claudio Cecone (C)

Department of Chemistry, University of Torino, via P. Giuria 7, 10125, Torino, Italy.

Alberto Rubin Pedrazzo (AR)

Department of Chemistry, University of Torino, via P. Giuria 7, 10125, Torino, Italy.

Roberta Cavalli (R)

Department of Drug Science and Technology, University of Torino, via P. Giuria 9, 10125, Torino, Italy.

Chiara Dianzani (C)

Department of Drug Science and Technology, University of Torino, via P. Giuria 9, 10125, Torino, Italy.

Francesco Trotta (F)

Department of Chemistry, University of Torino, via P. Giuria 7, 10125, Torino, Italy. Electronic address: francesco.trotta@unito.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH